Aug 9 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2019 Jun 30, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 4.50 4.35 20.10
(+3.4 pct) (+12.2 pct) (+4.4 pct)
Operating 673 mln 441 mln 3.18
(+52.5 pct) (+77.4 pct) (+2.7 pct)
Recurring 673 mln 446 mln 3.17
(+51.0 pct) (+79.9 pct) (+2.2 pct)
Net 428 mln 287 mln 2.16
(+49.4 pct) (+88.3 pct) (+3.4 pct)
EPS 109.06 yen 72.99 yen 549.12 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T